Management of hepatitis C after transplantation: a long way from success

Recurrence of hepatitis C after transplantation is expected. Unfortunately, the outcome is poor in some, with as many as 25% of patients developing decompensated cirrhosis. Thus, developing treatment strategies to eradicate infection or slow the progression of hepatic fibrosis is crucial. The publis...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of gastroenterology & hepatology Vol. 16; no. 11; p. 1131
Main Author Dove, Lorna M
Format Journal Article
LanguageEnglish
Published England 01.11.2004
Subjects
Genotype
Hepatitis C - prevention & control
Hepatitis C - virology
Humans
Liver Cirrhosis - prevention & control
Liver Transplantation
Postoperative Complications - prevention & control
Secondary Prevention
Online AccessGet more information

Cover

More Information
Summary:Recurrence of hepatitis C after transplantation is expected. Unfortunately, the outcome is poor in some, with as many as 25% of patients developing decompensated cirrhosis. Thus, developing treatment strategies to eradicate infection or slow the progression of hepatic fibrosis is crucial. The published data on treatment in this population is limited with viral response rates reported anywhere from 0-48%. Furthermore, the poor tolerability of therapy is highlighted in the Berenguer article. These data emphasize the importance of developing effective non-interferon based therapies for the post-transplant patient.
ISSN:0954-691X
1473-5687
DOI:10.1097/00042737-200411000-00008